2026 Annual Meeting | C167 - Clinical Trials in Action: Research Site Models, Recruitment, and Operations

Date Wednesday 04/22/26

Time 07:00 AM - 09:00 AM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Michael Soileau, MD, FAAN

Topic(s) Practice, Policy, and Ethics

Learning Objectives Participants should become familiar with the value and process of incorporating clinical trials into their practice, covering site models, recruitment strategies, and operational steps, and gain practical insights into trial startup and maintenance to support successful research integration.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Systems-based Practice

Program Level Introductory

Recommended Audience General Neurologist, Specialist Neurologist, Advanced Practice Provider, Business Administrator, Coordinator

Teaching Styles Didactic

Event Timeline
07:00 AM - 07:45 AM CDT	Speaker	Designing Clinical Trial Sites: Efficiency, Scale, and Sustainability Deena Kuruvilla, MD
07:45 AM - 08:30 AM CDT	Speaker	Modern Recruitment and Retention Strategies in Clinical Trials Belinda A. Savage-Edwards, MD, FAAN
08:30 AM - 09:00 AM CDT	Q&A	Questions and Answers Michael Soileau, MD, FAAN, Belinda A. Savage-Edwards, MD, FAAN, Deena Kuruvilla, MD

Faculty Disclosures
Deena Kuruvilla, MD	Dr. Kuruvilla has received personal compensation for serving as an employee of Cefaly. Dr. Kuruvilla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Kuruvilla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Kuruvilla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan. Dr. Kuruvilla has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Kuruvilla has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for amgen. Dr. Kuruvilla has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for allergan/abbvie. Dr. Kuruvilla has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Healthline . Dr. Kuruvilla has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Abbvie/Allergan. Dr. Kuruvilla has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for ESTES, INGRAM, FOELS & GIBBS, P.A.
Belinda A. Savage-Edwards, MD, FAAN	The institution of Dr. Savage-Edwards has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Llly. The institution of Dr. Savage-Edwards has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Easai. The institution of Dr. Savage-Edwards has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Savage-Edwards has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Association of Neurology Journal. Dr. Savage-Edwards has or had stock in Eli Lilly.Dr. Savage-Edwards has or had stock in AbbVie. The institution of Dr. Savage-Edwards has received research support from Eli LIlly Co.. The institution of Dr. Savage-Edwards has received research support from AbbVie. The institution of Dr. Savage-Edwards has received research support from IQVIA.
Michael Soileau, MD, FAAN	The institution of Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. The institution of Dr. Soileau has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Soileau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Soileau has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie. Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Soileau has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merz. The institution of Dr. Soileau has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Soileau has received research support from Abbvie. The institution of Dr. Soileau has received research support from Cerevel. The institution of Dr. Soileau has received research support from Praxis. The institution of Dr. Soileau has received research support from CND Life Sciences. The institution of Dr. Soileau has received research support from Teva. The institution of Dr. Soileau has received research support from Abbott. The institution of Dr. Soileau has received research support from Jazz Pharmaceuticals. The institution of Dr. Soileau has received research support from Scion. Dr. Soileau has received publishing royalties from a publication relating to health care. Dr. Soileau has a non-compensated relationship as a Past President with Texas Neurological Society that is relevant to AAN interests or activities.

��ɫ��

��ɫ��